A Study Conducted to Evaluate the Conjunctiva and Tenon's Capsule Status of Healthy Subjects and in Participants With Neovascular Age-related Macular Degeneration (nAMD)/Diabetic Macular Edema (DME)

  • Eye Disorder
  • Diabetic Macular Edema
  • Wet Age-Related Macular Degeneration
Please note that the recruitment status of the study at your site may differ from the overall study status because some study sites may recruit earlier than others.
Study Status:

Recruiting

This study runs in
Cities
  • Barcelona
  • burjassot
  • Córdoba
  • Madrid
  • Majadahonda
  • Oviedo
  • Pamplona
  • San Cugat Del Valles
  • Valladolid
  • València
Trial Identifier:

NCT06723288 MR45734

      Show study locations

      The source of the below information is public registry websites such as ClinicalTrials.gov, EuClinicalTrials.eu, ISRCTN.com, etc.. It has been summarised and edited into simpler language. For more information about this clinical study see the For Expert tab on the specific ForPatients page or follow these links to https://clinicaltrials.gov and/or https://euclinicaltrials.eu and/or https://www.isrctn.com.

      The below information is taken directly from public registry websites such as ClinicalTrials.gov, EuClinicalTrials.eu, ISRCTN.com, etc., and has not been edited.

      Results Disclaimer

      Study Summary

      The purpose of this study is to obtain conjunctiva and tenon's capsule thickness measurements in vivo using spectral domain-optical coherence tomography (SD-OCT) in participants with nAMD/DME and age-matched healthy subjects.

      Hoffmann-La Roche Sponsor
      N/A Phase
      NCT06723288, MR45734 Trial Identifier
      Neovascular Age-related Macular Degeneration, Diabetic Macular Edema Condition
      Official Title

      A Multicenter, Cross-sectional Study to Describe the Conjunctiva and Tenon's Capsule Status of Healthy Subjects and nAMD/DME Patients Followed in Clinical Practice in Spain

      Eligibility Criteria

      All Gender
      ≥45 Years Age
      Yes Healthy Volunteers
      Inclusion Criteria

      For nAMD/DME participants:

      • Diagnosis of nAMD/DME

      For healthy subjects:

      • Normal visual function
      Exclusion Criteria
      • Current or past treatment for glaucoma (only for healthy subjects)
      • Dry eye disease except those treated only with artificial tears
      • Ocular hypertension treated with hypotensive drugs
      • Pterygium
      • Strabismus
      • Previous ocular surgery except cataract surgery
      • Cataract surgery with scleral incision
      • Current contact lens wearers
      • Myopia with more than 6 diopters
      • Corneal transplant
      • History of ocular surface inflammation
      • Active or recent conjunctivitis infection
      • Pregnancy
      • Participant who has already received an IVT injection in the superotemporal quadrant (only for nAMD/DME participants)

      For the latest version of this information please go to www.forpatients.roche.com

       

      Related Studies

      Use our search to find other trials on Genentech Clinical Trials in related disease areas.

      Diabetic Macular Edema Wet Age-Related Macular Degeneration

      About Clinical Research

      What is a clinical trial? Why should I consider taking part in a clinical trial? And why does Genentech conduct clinical trials?

      Find out now